INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.86
+0.57 (7.82%)
At close: May 16, 2025, 4:00 PM
7.93
+0.07 (0.89%)
After-hours: May 16, 2025, 7:58 PM EDT
INmune Bio Employees
As of December 31, 2024, INmune Bio had 22 total employees, including 13 full-time and 9 part-time employees. The number of employees increased by 5 or 29.41% compared to the previous year.
Employees
22
Change (1Y)
5
Growth (1Y)
29.41%
Revenue / Employee
$2,273
Profits / Employee
-$1,854,364
Market Cap
182.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
INMB News
- 2 days ago - INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity - Seeking Alpha
- 8 days ago - INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 12 days ago - INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - GlobeNewsWire
- 4 weeks ago - INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness - GlobeNewsWire
- 7 weeks ago - INmune Bio, Inc. (INMB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update - GlobeNewsWire
- 2 months ago - Undercovered Dozen: INmune Bio, Primerica, First Quantum, Pinnacle West + - Seeking Alpha